# Antenatal Allopurinol in Intrauterine Growth Restriction

> **NCT00346463** · NA · UNKNOWN · sponsor: **UMC Utrecht** · enrollment: 50 (estimated)

## Conditions studied

- Fetal Growth Retardation

## Interventions

- **DRUG:** Allopurinol

## Key facts

- **NCT ID:** NCT00346463
- **Lead sponsor:** UMC Utrecht
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-07
- **Primary completion:** —
- **Final completion:** 2013-07
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2008-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00346463

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00346463, "Antenatal Allopurinol in Intrauterine Growth Restriction". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00346463. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*